drugset / Trial / NCT00191581

Local Registration Trial in China Humalog Mix 50

NCT00191581

Phase 3 Completed 120 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of this study is to compare the 2-hour PPBG excursion following a standard test meal in insulin-requiring diabetic patients treated twice daily with human insulin mix 50/50, versus the 2-hour PPBG excursion in patients treated twice daily with insulin lispro mix 50/50.

Timeline

Start
2005-03
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic
Subject Insulin Lispro Protein / enzyme biologic